Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855357 · ClinicalTrials.gov registry record · NA
Smoke-free Home Intervention in Permanent Supportive Housing
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 452
- Enrollment target
NCT04855357: Completed NA study, sponsored by University of California, San Francisco.
NCT04855357 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 452 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04855357, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 452 participants
- Enrollment target
Study Summary
The focus of this study is on expanding access to voluntary smoke-free homes to formerly homeless residents residing in permanent supportive housing and examining the impact of this intervention on reducing tobacco-caused disparities. In this study, the principal investigator will conduct a multi-site, community-based cluster-randomized wait-list controlled trial of the multi-faceted smoke-free home intervention among 400 permanent supportive housing residents residing in 20 permanent supportive housing sites across the San Francisco Bay Area with the goal of increasing voluntary adoption of smoke-free homes.
Primary Outcome
The proportion of resident-participants who self-reported a voluntary adoption of smoke-free homes for \>=90 days at 6 months follow-up will be reported.
Interventions
- BEHAVIORAL Resident counselling
- BEHAVIORAL Staff Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2022-01-24 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT04855357 record still lists
NCT04855357 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Resident counselling is the first listed.
NCT04855357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04855357 about?
NCT04855357 is a clinical study titled "Smoke-free Home Intervention in Permanent Supportive Housing". The focus of this study is on expanding access to voluntary smoke-free homes to formerly homeless residents residing in permanent supportive housing and examining the impact of this intervention on reducing tobacco-caused disparities. In this study, the principal investigator will conduct a multi-si...
What is the current status of trial NCT04855357?
This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2022-01-24. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04855357?
The interventions under investigation include: Resident counselling (BEHAVIORAL), Staff Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04855357?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04855357's enrollment target sits among peer trials
452 225th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI